Aurora Cannabis Inc. (ACB)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.32 |
| Open | 5.30 |
| Bid | 5.25 x 200 |
| Ask | 5.28 x 200 |
| Day's Range | 5.14 - 5.34 |
| 52 Week Range | 2.84 - 9.35 |
| Volume | |
| Avg. Volume | 1,247,606 |
| Market Cap | 292.353M |
| Beta (5Y Monthly) | 2.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.51 |
ZacksACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
- Baystreet
Stocks in play: Aurora Cannabis Inc.
Announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia ...
PR NewswireAurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs. Jose Celedon, Principal Scie
© 2024 Yahoo. All rights reserved.